MARKET

APM

APM

Aptorum Group Ltd
NASDAQ
0.7740
-0.0025
-0.32%
After Hours: 0.7614 -0.0126 -1.63% 18:09 06/26 EDT
OPEN
0.7585
PREV CLOSE
0.7765
HIGH
0.8370
LOW
0.7585
VOLUME
32.92K
TURNOVER
--
52 WEEK HIGH
4.470
52 WEEK LOW
0.6500
MARKET CAP
6.30M
P/E (TTM)
-4.1748
1D
5D
1M
3M
1Y
5Y
1D
Aptorum amends 6-K to extend DiamiR merger termination date to July 31, 2026
PUBT · 6d ago
Aptorum Group announces collaboration between DiamiR, AlzLabs
TipRanks · 6d ago
Aptorum Group Announces Collaboration Between DiamiR And AlzLabs Precision Diagnostics To Generate Protein And MicroRNA Blood-Based Biomarker Data With Focus On Alzheimer's Disease
Benzinga · 06/22 12:11
Aptorum announces DiamiR-AlzLabs collaboration on blood-based Alzheimer’s biomarkers
PUBT · 06/22 12:03
APTORUM GROUP ANNOUNCES COLLABORATION BETWEEN DIAMIR BIOSCIENCES AND ALZLABS PRECISION DIAGNOSTICS FOR ALZHEIMER’S DISEASE BIOMARKERS
Reuters · 06/22 12:00
Weekly Report: what happened at APM last week (0615-0619)?
Weekly Report · 06/22 10:16
Weekly Report: what happened at APM last week (0608-0612)?
Weekly Report · 06/15 10:17
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 06/10 17:05
More
About APM
Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

Webull offers Aptorum Group Ltd stock information, including NASDAQ: APM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APM stock methods without spending real money on the virtual paper trading platform.